9-(2'-O-Acetyl-5'-O-benzoyl-3'-O-Methyl-beta-D-ribofuranosyl)-2,6-dichloropurine manufacturers
|
| | 9-(2'-O-Acetyl-5'-O-benzoyl-3'-O-Methyl-beta-D-ribofuranosyl)-2,6-dichloropurine Basic information |
| | 9-(2'-O-Acetyl-5'-O-benzoyl-3'-O-Methyl-beta-D-ribofuranosyl)-2,6-dichloropurine Chemical Properties |
| | 9-(2'-O-Acetyl-5'-O-benzoyl-3'-O-Methyl-beta-D-ribofuranosyl)-2,6-dichloropurine Usage And Synthesis |
| Uses | 9-(2’-O-Acetyl-5’-O-benzoyl-3’-O-methyl-beta-D-ribofuranosyl)-2,6-dichloropurine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 9-(2'-O-Acetyl-5'-O-benzoyl-3'-O-Methyl-beta-D-ribofuranosyl)-2,6-dichloropurine Preparation Products And Raw materials |
|